It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
During this period, a total of 30 countries from all WHO regions reported oseltamivir resistance for 1291 of 1362 A(H1N1) viruses analysed. The prevalence of oseltamivir resistance was very high in the following countries/territory: Canada (52 of 52 tested), Hong Kong SAR (72 of 80), Japan (420 of 422), the Republic of Korea (268 of 269) and the United States of America (237 of 241).
The resistance prevalence was relatively low in China (6 of 44 tested). In Europe, H1N1 circulation was low during this period while the resistance prevalence was high: France (12 of 12tested), Germany (66 of 67), Ireland (9 of 10), Italy (16 of 16), Sweden (11 of 12) and the United Kingdom (61 of 62).
Originally posted by Shere Khaan
What it means is the existing strains of H1N1 in circulation have built up a resistance to Tamiflu (oseltamivir is the drug name and tamiflu is the brand name of that drug). You'll notice that teh US has an almost total resistance to Tamiflu in it's circulating H1N1 viruses.
The implications are twofold. Firstly H1N1 can recombine with other clades of itself. Secondly it shows just how fast it adapted tor esist tamiflu.
Originally posted by digitalwarrior
so this mean china would be theoretically the only country where it could not outbreak?